CME Group Inc. $CME Shares Sold by FUKOKU MUTUAL LIFE INSURANCE Co

FUKOKU MUTUAL LIFE INSURANCE Co decreased its holdings in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 12.4% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,526 shares of the financial services provider’s stock after selling 216 shares during the period. FUKOKU MUTUAL LIFE INSURANCE Co’s holdings in CME Group were worth $421,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the business. Webster Bank N. A. boosted its stake in shares of CME Group by 206.9% in the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after buying an additional 60 shares in the last quarter. Highline Wealth Partners LLC raised its position in CME Group by 84.3% in the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 43 shares in the last quarter. Ransom Advisory Ltd acquired a new stake in CME Group in the first quarter valued at $31,000. Trifecta Capital Advisors LLC lifted its holdings in CME Group by 59.2% in the second quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock valued at $31,000 after acquiring an additional 42 shares during the period. Finally, Westside Investment Management Inc. boosted its position in shares of CME Group by 105.0% during the 2nd quarter. Westside Investment Management Inc. now owns 123 shares of the financial services provider’s stock worth $34,000 after purchasing an additional 63 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, insider Sunil Cutinho sold 11,896 shares of CME Group stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the sale, the insider owned 17,440 shares in the company, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Timothy Francis Mccourt sold 379 shares of the business’s stock in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the completion of the transaction, the insider directly owned 9,508 shares of the company’s stock, valued at $2,470,463.64. The trade was a 3.83% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 14,043 shares of company stock valued at $3,791,486. Company insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

CME has been the subject of a number of research analyst reports. Rothschild & Co Redburn increased their price target on shares of CME Group from $297.00 to $300.00 and gave the company a “neutral” rating in a report on Thursday, November 6th. Oppenheimer upped their target price on shares of CME Group from $300.00 to $303.00 and gave the stock an “outperform” rating in a research report on Thursday, July 24th. UBS Group dropped their target price on shares of CME Group from $285.00 to $280.00 and set a “neutral” rating for the company in a report on Thursday, October 23rd. The Goldman Sachs Group boosted their price target on CME Group from $262.00 to $263.00 and gave the stock a “sell” rating in a research note on Thursday, October 23rd. Finally, Keefe, Bruyette & Woods upped their price target on CME Group from $283.00 to $287.00 and gave the stock a “market perform” rating in a report on Monday, October 13th. Eight research analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, CME Group presently has a consensus rating of “Hold” and an average target price of $287.65.

Check Out Our Latest Research Report on CME Group

CME Group Stock Performance

Shares of CME opened at $272.49 on Thursday. CME Group Inc. has a 12-month low of $224.62 and a 12-month high of $290.79. The stock has a market cap of $98.26 billion, a P/E ratio of 26.40, a PEG ratio of 4.41 and a beta of 0.38. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The company has a 50-day moving average of $268.27 and a two-hundred day moving average of $272.82.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.63 by $0.05. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The business had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period in the prior year, the business earned $2.68 earnings per share. The company’s quarterly revenue was down 3.0% on a year-over-year basis. As a group, research analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th will be given a dividend of $1.25 per share. The ex-dividend date of this dividend is Friday, December 12th. This represents a $5.00 annualized dividend and a yield of 1.8%. CME Group’s dividend payout ratio (DPR) is presently 48.45%.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.